Gefitinib ("Iressa", ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, reverses breast cancer resistance protein/ABCG2-mediated drug resistance.

Source:http://linkedlifedata.com/resource/pubmed/id/15735043

Cancer Res. 2005 Feb 15 65 4 1541-6

Download in:

View as

General Info

PMID
15735043